By Dr Lucy Coupland

Journal articles

Tonkin A; Alyward P; Colquhoun D; Glasziou P; Harris P; Hunt D; Keech A; MacMahon S; Magnus P; Newel D; Nestel P; Sharpe N; Shaw J; Simes RJ; Thompson P; Thompson A; West M; White H; Simes S; Hague W; Caleo S; Hall J; Martin A; Mulray S; Barter P; Beilin L; Collins R; McNeil J; Meier P; Willimott H; Smithers D; Wallace P; Baker J; Hobbs M; Sullivan D; Anderson N; Hankey G; Watson J; Arulchelvam M; Chup S; Daly J; Hanna J; Leach A; Lee M; Loughhead J; Lundie-Jenkin H; Morrison J; Netting S; Nguyen A; Pater H; Philip R; Pinna G; Rattos D; Ryerson S; Sazhin V; Walsh R; Claque A; Mackie M; Yallop J; Boss K; Shepard M; Leach J; Gandy M; Joughin J; Seabrook J; Abraham R; Allen J; Bates F; Beinart I; Breed E; Brown D; Bunyan N; Calvert D; Campbell T; Condon-Paoloni D; Conway B; Coupland L; Crowe J; Cunio N; Cuthbert B; Cuthbert N; D'Arcy S; Davidson P; Dwyer B; England J; Friend C; Fulcher G; Grant S; Hellestrand K; Kava M; Kritharides L; McGill D; McKee H; McLean A; Neaverson M; Nelson G; O'Neill M; Onuma C; O'Reilly F, 1998, 'Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels', New England Journal of Medicine, 339, pp. 1349 - 1357, http://dx.doi.org/10.1056/NEJM199811053391902

Tonkin A; Aylward P; Colquhoun D; Glasziou P; Harris P; Hunt D; MacMahon S; Nestel P; Sharpe N; Símes J; Thompson P; Thomson A; West M; White H; Shaw J; Ablett M; MacAskill M; Turner R; Magnus P; Wallace P; Keech A; Newell D; Raupach H; Hague W; Hall J; Mulray S; Wiseman V; Davies P; Smithers D; Baker J; Hobbs M; Sullivan D; Daly J; Lundie-Jenkins H; Morrison J; Pater H; Philip R; Ryerson S; Simes S; Sazhin V; Martin A; Nguyen A; Drew J; Rattos D; Clague A; Hall A; Mackie M; Yallop J; Boss K; Barter P; Beilin L; Collins R; McNeil J; Meier P; Willimott H; Whiting M; Shepard M; Leach J; Gandy M; Joughan J; Seabrook J; Coupland L; McGill D; Tarimer P; Beinart I; McKee H; Abraham R; Parnell G; England J; Viles A; Bunyan N; Grant S; O'Neill M; Wikramanayake R; Brown-Paul P; Crowe J; Waites J; Walker R; Allen J; Marel M; Pawsey C; Wyndham R; Bates F; Brown D; Thomas J; Woods J; Hellestrand K; Paterson S; Calvert D; Condon-Paoloni D; Owensby A; Owensby D; Ryan J; Silberberg J; Taylor M; Onuma S; Wee K; Kava M; McLean A; Quinn K, 1995, 'Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris', American Journal of Cardiology, 76, pp. 474 - 479, http://dx.doi.org/10.1016/S0002-9149(99)80133-7

Back to profile page